Faeth Therapeutics, Inc (FTH) Price Prediction & ForecastFTHFaeth Therapeutics, Inc

Alphio's FTH stock price prediction model matches the current Faeth Therapeutics, Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $20.61 (+0.18%). The 1-week path is $20.64 (+0.36%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Faeth Therapeutics is not a good buy right now due to its extremely low RSI of 15.478, indicating oversold conditions, and a significant recent price drop of 27.78% over the last five days. The company is facing substantial losses, with a net income loss of $170 million in Q1 2026 and a forward P/E ratio of 0, suggesting no earnings growth is expected in the near future. While there are positive catalysts related to the PIKTOR drug, the current financial instability and high volatility present significant risks.

Faeth Therapeutics, Inc (FTH) last closed at $20.57, losing -1.06%. These facts feed the 1-day and 1-week FTH price prediction above.